nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.141	0.314	CbGbCtD
Mitoxantrone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0663	0.148	CbGbCtD
Mitoxantrone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0448	0.0998	CbGbCtD
Mitoxantrone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0427	0.0952	CbGbCtD
Mitoxantrone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0381	0.0848	CbGbCtD
Mitoxantrone—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0373	0.0831	CbGbCtD
Mitoxantrone—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0352	0.0785	CbGbCtD
Mitoxantrone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0223	0.0498	CbGbCtD
Mitoxantrone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0211	0.047	CbGbCtD
Mitoxantrone—BTK—connective tissue—chronic obstructive pulmonary disease	0.00586	0.0968	CbGeAlD
Mitoxantrone—PIM1—respiratory system—chronic obstructive pulmonary disease	0.00576	0.0952	CbGeAlD
Mitoxantrone—BTK—bronchus—chronic obstructive pulmonary disease	0.00547	0.0905	CbGeAlD
Mitoxantrone—PIM1—connective tissue—chronic obstructive pulmonary disease	0.00507	0.0838	CbGeAlD
Mitoxantrone—PIM1—bronchus—chronic obstructive pulmonary disease	0.00474	0.0784	CbGeAlD
Mitoxantrone—PIM1—trachea—chronic obstructive pulmonary disease	0.00426	0.0704	CbGeAlD
Mitoxantrone—TOP2A—Salmeterol—Salbutamol—chronic obstructive pulmonary disease	0.00389	0.807	CbGdCrCtD
Mitoxantrone—BTK—lung—chronic obstructive pulmonary disease	0.00353	0.0584	CbGeAlD
Mitoxantrone—PIM1—lung—chronic obstructive pulmonary disease	0.00306	0.0506	CbGeAlD
Mitoxantrone—TOP2A—bronchus—chronic obstructive pulmonary disease	0.00278	0.046	CbGeAlD
Mitoxantrone—CYP1B1—respiratory system—chronic obstructive pulmonary disease	0.00226	0.0374	CbGeAlD
Mitoxantrone—CYP1B1—connective tissue—chronic obstructive pulmonary disease	0.00199	0.0329	CbGeAlD
Mitoxantrone—CYP1B1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00182	0.0301	CbGeAlD
Mitoxantrone—TOP2A—lung—chronic obstructive pulmonary disease	0.00179	0.0297	CbGeAlD
Mitoxantrone—ABCC1—bronchus—chronic obstructive pulmonary disease	0.00168	0.0277	CbGeAlD
Mitoxantrone—SLC47A1—lung—chronic obstructive pulmonary disease	0.00164	0.0271	CbGeAlD
Mitoxantrone—ABCC1—trachea—chronic obstructive pulmonary disease	0.0015	0.0249	CbGeAlD
Mitoxantrone—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.00146	0.0241	CbGeAlD
Mitoxantrone—CYP1B1—lung—chronic obstructive pulmonary disease	0.0012	0.0199	CbGeAlD
Mitoxantrone—ABCC1—lung—chronic obstructive pulmonary disease	0.00108	0.0179	CbGeAlD
Mitoxantrone—ABCG2—lung—chronic obstructive pulmonary disease	0.000895	0.0148	CbGeAlD
Mitoxantrone—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000831	0.0137	CbGeAlD
Mitoxantrone—CYP2E1—lung—chronic obstructive pulmonary disease	0.000775	0.0128	CbGeAlD
Mitoxantrone—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000631	0.00193	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000629	0.00193	CcSEcCtD
Mitoxantrone—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000623	0.00191	CcSEcCtD
Mitoxantrone—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00062	0.0019	CcSEcCtD
Mitoxantrone—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000616	0.00188	CcSEcCtD
Mitoxantrone—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000616	0.00188	CcSEcCtD
Mitoxantrone—ABCB1—trachea—chronic obstructive pulmonary disease	0.000614	0.0101	CbGeAlD
Mitoxantrone—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000608	0.00186	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000599	0.00183	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000598	0.00183	CcSEcCtD
Mitoxantrone—Cough—Formoterol—chronic obstructive pulmonary disease	0.000596	0.00182	CcSEcCtD
Mitoxantrone—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000596	0.00182	CcSEcCtD
Mitoxantrone—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00059	0.00181	CcSEcCtD
Mitoxantrone—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000589	0.0018	CcSEcCtD
Mitoxantrone—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000589	0.0018	CcSEcCtD
Mitoxantrone—Cough—Montelukast—chronic obstructive pulmonary disease	0.000583	0.00179	CcSEcCtD
Mitoxantrone—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000581	0.00178	CcSEcCtD
Mitoxantrone—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000581	0.00178	CcSEcCtD
Mitoxantrone—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000581	0.00178	CcSEcCtD
Mitoxantrone—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000581	0.00178	CcSEcCtD
Mitoxantrone—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000581	0.00178	CcSEcCtD
Mitoxantrone—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000581	0.00178	CcSEcCtD
Mitoxantrone—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000581	0.00178	CcSEcCtD
Mitoxantrone—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000581	0.00178	CcSEcCtD
Mitoxantrone—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000579	0.00177	CcSEcCtD
Mitoxantrone—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000579	0.00177	CcSEcCtD
Mitoxantrone—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000579	0.00177	CcSEcCtD
Mitoxantrone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000579	0.00177	CcSEcCtD
Mitoxantrone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000579	0.00177	CcSEcCtD
Mitoxantrone—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000574	0.00176	CcSEcCtD
Mitoxantrone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000574	0.00176	CcSEcCtD
Mitoxantrone—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000569	0.00174	CcSEcCtD
Mitoxantrone—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000569	0.00174	CcSEcCtD
Mitoxantrone—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000567	0.00174	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000564	0.00173	CcSEcCtD
Mitoxantrone—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000562	0.00172	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000557	0.00171	CcSEcCtD
Mitoxantrone—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000557	0.00171	CcSEcCtD
Mitoxantrone—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000557	0.00171	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000557	0.00171	CcSEcCtD
Mitoxantrone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000556	0.0017	CcSEcCtD
Mitoxantrone—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000556	0.0017	CcSEcCtD
Mitoxantrone—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000553	0.00169	CcSEcCtD
Mitoxantrone—Infection—Formoterol—chronic obstructive pulmonary disease	0.000553	0.00169	CcSEcCtD
Mitoxantrone—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000549	0.00168	CcSEcCtD
Mitoxantrone—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000549	0.00168	CcSEcCtD
Mitoxantrone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000549	0.00168	CcSEcCtD
Mitoxantrone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000548	0.00168	CcSEcCtD
Mitoxantrone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000547	0.00167	CcSEcCtD
Mitoxantrone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000546	0.00167	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000546	0.00167	CcSEcCtD
Mitoxantrone—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000546	0.00167	CcSEcCtD
Mitoxantrone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000544	0.00166	CcSEcCtD
Mitoxantrone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000544	0.00166	CcSEcCtD
Mitoxantrone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000542	0.00166	CcSEcCtD
Mitoxantrone—Infection—Montelukast—chronic obstructive pulmonary disease	0.000542	0.00166	CcSEcCtD
Mitoxantrone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000541	0.00166	CcSEcCtD
Mitoxantrone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000541	0.00166	CcSEcCtD
Mitoxantrone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000539	0.00165	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000534	0.00164	CcSEcCtD
Mitoxantrone—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000533	0.00163	CcSEcCtD
Mitoxantrone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00053	0.00162	CcSEcCtD
Mitoxantrone—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000526	0.00161	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000526	0.00161	CcSEcCtD
Mitoxantrone—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000523	0.0016	CcSEcCtD
Mitoxantrone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000521	0.00159	CcSEcCtD
Mitoxantrone—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000521	0.00159	CcSEcCtD
Mitoxantrone—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000518	0.00158	CcSEcCtD
Mitoxantrone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000517	0.00158	CcSEcCtD
Mitoxantrone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000513	0.00157	CcSEcCtD
Mitoxantrone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000511	0.00156	CcSEcCtD
Mitoxantrone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000509	0.00156	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000509	0.00156	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000508	0.00155	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000508	0.00155	CcSEcCtD
Mitoxantrone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000501	0.00153	CcSEcCtD
Mitoxantrone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000501	0.00153	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000497	0.00152	CcSEcCtD
Mitoxantrone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000497	0.00152	CcSEcCtD
Mitoxantrone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000497	0.00152	CcSEcCtD
Mitoxantrone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000495	0.00152	CcSEcCtD
Mitoxantrone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000495	0.00152	CcSEcCtD
Mitoxantrone—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000492	0.00151	CcSEcCtD
Mitoxantrone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000492	0.0015	CcSEcCtD
Mitoxantrone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00049	0.0015	CcSEcCtD
Mitoxantrone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00049	0.0015	CcSEcCtD
Mitoxantrone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00049	0.0015	CcSEcCtD
Mitoxantrone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000485	0.00148	CcSEcCtD
Mitoxantrone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000483	0.00148	CcSEcCtD
Mitoxantrone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00048	0.00147	CcSEcCtD
Mitoxantrone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00048	0.00147	CcSEcCtD
Mitoxantrone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00048	0.00147	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000479	0.00147	CcSEcCtD
Mitoxantrone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000476	0.00146	CcSEcCtD
Mitoxantrone—Pain—Formoterol—chronic obstructive pulmonary disease	0.000476	0.00146	CcSEcCtD
Mitoxantrone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000476	0.00146	CcSEcCtD
Mitoxantrone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000476	0.00146	CcSEcCtD
Mitoxantrone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000472	0.00145	CcSEcCtD
Mitoxantrone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00047	0.00144	CcSEcCtD
Mitoxantrone—TOP2A—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.00047	0.0975	CbGdCrCtD
Mitoxantrone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000469	0.00144	CcSEcCtD
Mitoxantrone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000468	0.00143	CcSEcCtD
Mitoxantrone—Pain—Montelukast—chronic obstructive pulmonary disease	0.000467	0.00143	CcSEcCtD
Mitoxantrone—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000466	0.00143	CcSEcCtD
Mitoxantrone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000465	0.00142	CcSEcCtD
Mitoxantrone—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000464	0.00142	CcSEcCtD
Mitoxantrone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000463	0.00142	CcSEcCtD
Mitoxantrone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000462	0.00141	CcSEcCtD
Mitoxantrone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000461	0.00141	CcSEcCtD
Mitoxantrone—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00046	0.00141	CcSEcCtD
Mitoxantrone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000459	0.00141	CcSEcCtD
Mitoxantrone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000459	0.00141	CcSEcCtD
Mitoxantrone—TOP2A—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.000459	0.0951	CbGdCrCtD
Mitoxantrone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000459	0.0014	CcSEcCtD
Mitoxantrone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000457	0.0014	CcSEcCtD
Mitoxantrone—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000457	0.0014	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000456	0.00139	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000456	0.00139	CcSEcCtD
Mitoxantrone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000453	0.00139	CcSEcCtD
Mitoxantrone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00138	CcSEcCtD
Mitoxantrone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00138	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000446	0.00137	CcSEcCtD
Mitoxantrone—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000446	0.00137	CcSEcCtD
Mitoxantrone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000443	0.00135	CcSEcCtD
Mitoxantrone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000443	0.00135	CcSEcCtD
Mitoxantrone—ABCB1—lung—chronic obstructive pulmonary disease	0.000441	0.00729	CbGeAlD
Mitoxantrone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00044	0.00135	CcSEcCtD
Mitoxantrone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00044	0.00135	CcSEcCtD
Mitoxantrone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00044	0.00135	CcSEcCtD
Mitoxantrone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00044	0.00135	CcSEcCtD
Mitoxantrone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000439	0.00134	CcSEcCtD
Mitoxantrone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000435	0.00133	CcSEcCtD
Mitoxantrone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000435	0.00133	CcSEcCtD
Mitoxantrone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000435	0.00133	CcSEcCtD
Mitoxantrone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000433	0.00133	CcSEcCtD
Mitoxantrone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000433	0.00133	CcSEcCtD
Mitoxantrone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000432	0.00132	CcSEcCtD
Mitoxantrone—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000432	0.00132	CcSEcCtD
Mitoxantrone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000431	0.00132	CcSEcCtD
Mitoxantrone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000431	0.00132	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00043	0.00132	CcSEcCtD
Mitoxantrone—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000427	0.00131	CcSEcCtD
Mitoxantrone—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000425	0.0013	CcSEcCtD
Mitoxantrone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000418	0.00128	CcSEcCtD
Mitoxantrone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000416	0.00127	CcSEcCtD
Mitoxantrone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000416	0.00127	CcSEcCtD
Mitoxantrone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00041	0.00126	CcSEcCtD
Mitoxantrone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00041	0.00126	CcSEcCtD
Mitoxantrone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00041	0.00126	CcSEcCtD
Mitoxantrone—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000406	0.00124	CcSEcCtD
Mitoxantrone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000402	0.00123	CcSEcCtD
Mitoxantrone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.0004	0.00122	CcSEcCtD
Mitoxantrone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.0004	0.00122	CcSEcCtD
Mitoxantrone—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000393	0.0012	CcSEcCtD
Mitoxantrone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000391	0.0012	CcSEcCtD
Mitoxantrone—CYP1B1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000389	0.00244	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.00119	CcSEcCtD
Mitoxantrone—CYP2E1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000387	0.00243	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000381	0.00117	CcSEcCtD
Mitoxantrone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.00117	CcSEcCtD
Mitoxantrone—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000381	0.00239	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.00038	0.00239	CbGpPWpGaD
Mitoxantrone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000379	0.00116	CcSEcCtD
Mitoxantrone—TOP2A—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000379	0.00238	CbGpPWpGaD
Mitoxantrone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000377	0.00116	CcSEcCtD
Mitoxantrone—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000376	0.00115	CcSEcCtD
Mitoxantrone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000373	0.00114	CcSEcCtD
Mitoxantrone—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.00113	CcSEcCtD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000364	0.00229	CbGpPWpGaD
Mitoxantrone—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00036	0.0011	CcSEcCtD
Mitoxantrone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.0011	CcSEcCtD
Mitoxantrone—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000355	0.00109	CcSEcCtD
Mitoxantrone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000354	0.00108	CcSEcCtD
Mitoxantrone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000354	0.00108	CcSEcCtD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000353	0.00222	CbGpPWpGaD
Mitoxantrone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.00108	CcSEcCtD
Mitoxantrone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000351	0.00108	CcSEcCtD
Mitoxantrone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.00107	CcSEcCtD
Mitoxantrone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000351	0.00107	CcSEcCtD
Mitoxantrone—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000351	0.00107	CcSEcCtD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000351	0.00221	CbGpPWpGaD
Mitoxantrone—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00035	0.0022	CbGpPWpGaD
Mitoxantrone—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000349	0.0022	CbGpPWpGaD
Mitoxantrone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00107	CcSEcCtD
Mitoxantrone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00107	CcSEcCtD
Mitoxantrone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000349	0.00107	CcSEcCtD
Mitoxantrone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000348	0.00107	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000348	0.00106	CcSEcCtD
Mitoxantrone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000347	0.00106	CcSEcCtD
Mitoxantrone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000344	0.00105	CcSEcCtD
Mitoxantrone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000344	0.00105	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000343	0.00105	CcSEcCtD
Mitoxantrone—CYP1B1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000342	0.00215	CbGpPWpGaD
Mitoxantrone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000342	0.00105	CcSEcCtD
Mitoxantrone—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000339	0.00104	CcSEcCtD
Mitoxantrone—CYP1B1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000338	0.00212	CbGpPWpGaD
Mitoxantrone—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000337	0.00103	CcSEcCtD
Mitoxantrone—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000337	0.00212	CbGpPWpGaD
Mitoxantrone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.00102	CcSEcCtD
Mitoxantrone—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000333	0.00102	CcSEcCtD
Mitoxantrone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.00102	CcSEcCtD
Mitoxantrone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000331	0.00101	CcSEcCtD
Mitoxantrone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000331	0.00101	CcSEcCtD
Mitoxantrone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000331	0.00101	CcSEcCtD
Mitoxantrone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00101	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000328	0.00206	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000327	0.00206	CbGpPWpGaD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000327	0.00205	CbGpPWpGaD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—CXCL8—chronic obstructive pulmonary disease	0.000324	0.00204	CbGpPWpGaD
Mitoxantrone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000324	0.000992	CcSEcCtD
Mitoxantrone—ABCG2—HIF-2-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000322	0.00202	CbGpPWpGaD
Mitoxantrone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00032	0.00098	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000319	0.00201	CbGpPWpGaD
Mitoxantrone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000319	0.000977	CcSEcCtD
Mitoxantrone—BTK—Immune System—LY96—chronic obstructive pulmonary disease	0.000318	0.002	CbGpPWpGaD
Mitoxantrone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000315	0.00198	CbGpPWpGaD
Mitoxantrone—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000314	0.000962	CcSEcCtD
Mitoxantrone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000313	0.00197	CbGpPWpGaD
Mitoxantrone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.000956	CcSEcCtD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—IL1B—chronic obstructive pulmonary disease	0.000311	0.00196	CbGpPWpGaD
Mitoxantrone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000311	0.000952	CcSEcCtD
Mitoxantrone—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00031	0.000949	CcSEcCtD
Mitoxantrone—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000309	0.00194	CbGpPWpGaD
Mitoxantrone—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000309	0.000945	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000302	0.000924	CcSEcCtD
Mitoxantrone—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000302	0.000924	CcSEcCtD
Mitoxantrone—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000297	0.000909	CcSEcCtD
Mitoxantrone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000294	0.000901	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000294	0.00185	CbGpPWpGaD
Mitoxantrone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000292	0.000893	CcSEcCtD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000291	0.00183	CbGpPWpGaD
Mitoxantrone—CYP1B1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000284	0.00179	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00028	0.00176	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000278	0.00175	CbGpPWpGaD
Mitoxantrone—SLC47A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000277	0.00174	CbGpPWpGaD
Mitoxantrone—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000276	0.000844	CcSEcCtD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000275	0.00173	CbGpPWpGaD
Mitoxantrone—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000273	0.000835	CcSEcCtD
Mitoxantrone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000271	0.000829	CcSEcCtD
Mitoxantrone—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000269	0.000822	CcSEcCtD
Mitoxantrone—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.00079	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000255	0.0016	CbGpPWpGaD
Mitoxantrone—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000254	0.0016	CbGpPWpGaD
Mitoxantrone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000253	0.000775	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.00025	0.00157	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.00025	0.00157	CbGpPWpGaD
Mitoxantrone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000249	0.000763	CcSEcCtD
Mitoxantrone—BTK—MyD88:Mal cascade initiated on plasma membrane—IL6—chronic obstructive pulmonary disease	0.000249	0.00157	CbGpPWpGaD
Mitoxantrone—ABCG2—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000249	0.00157	CbGpPWpGaD
Mitoxantrone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000249	0.000761	CcSEcCtD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000249	0.00156	CbGpPWpGaD
Mitoxantrone—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000248	0.00076	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000248	0.00156	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000247	0.00156	CbGpPWpGaD
Mitoxantrone—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000247	0.00155	CbGpPWpGaD
Mitoxantrone—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000242	0.000742	CcSEcCtD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00024	0.00151	CbGpPWpGaD
Mitoxantrone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00024	0.000734	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.000238	0.0015	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000238	0.0015	CbGpPWpGaD
Mitoxantrone—CYP1B1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000237	0.00149	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000236	0.00149	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000234	0.00147	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000234	0.00147	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000233	0.00147	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000233	0.00147	CbGpPWpGaD
Mitoxantrone—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000712	CcSEcCtD
Mitoxantrone—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00071	CcSEcCtD
Mitoxantrone—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000229	0.0007	CcSEcCtD
Mitoxantrone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000229	0.0007	CcSEcCtD
Mitoxantrone—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000228	0.000698	CcSEcCtD
Mitoxantrone—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000226	0.000692	CcSEcCtD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—TNF—chronic obstructive pulmonary disease	0.000226	0.00142	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—KL—chronic obstructive pulmonary disease	0.000224	0.00141	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000223	0.0014	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000222	0.00068	CcSEcCtD
Mitoxantrone—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000221	0.00139	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.00022	0.00138	CbGpPWpGaD
Mitoxantrone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000671	CcSEcCtD
Mitoxantrone—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000671	CcSEcCtD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000218	0.00137	CbGpPWpGaD
Mitoxantrone—CYP1B1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000218	0.00137	CbGpPWpGaD
Mitoxantrone—Infection—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000667	CcSEcCtD
Mitoxantrone—Shock—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00066	CcSEcCtD
Mitoxantrone—BTK—Activated TLR4 signalling—IL6—chronic obstructive pulmonary disease	0.000215	0.00135	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000215	0.00135	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000214	0.00135	CbGpPWpGaD
Mitoxantrone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000655	CcSEcCtD
Mitoxantrone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000213	0.000652	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000212	0.000649	CcSEcCtD
Mitoxantrone—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00064	CcSEcCtD
Mitoxantrone—BTK—DAP12 signaling—EGFR—chronic obstructive pulmonary disease	0.000208	0.00131	CbGpPWpGaD
Mitoxantrone—CYP1B1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000206	0.0013	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000205	0.00129	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000204	0.00128	CbGpPWpGaD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—IL6—chronic obstructive pulmonary disease	0.000202	0.00127	CbGpPWpGaD
Mitoxantrone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.0002	0.00126	CbGpPWpGaD
Mitoxantrone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000611	CcSEcCtD
Mitoxantrone—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.0002	0.00125	CbGpPWpGaD
Mitoxantrone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000197	0.00124	CbGpPWpGaD
Mitoxantrone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000603	CcSEcCtD
Mitoxantrone—BTK—DAP12 interactions—EGFR—chronic obstructive pulmonary disease	0.000195	0.00123	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—EGFR—chronic obstructive pulmonary disease	0.000195	0.00123	CbGpPWpGaD
Mitoxantrone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000591	CcSEcCtD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000191	0.0012	CbGpPWpGaD
Mitoxantrone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000583	CcSEcCtD
Mitoxantrone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.000582	CcSEcCtD
Mitoxantrone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.000582	CcSEcCtD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.00019	0.00119	CbGpPWpGaD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000189	0.00119	CbGpPWpGaD
Mitoxantrone—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000579	CcSEcCtD
Mitoxantrone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000579	CcSEcCtD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.000188	0.00118	CbGpPWpGaD
Mitoxantrone—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000574	CcSEcCtD
Mitoxantrone—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000186	0.00117	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000185	0.00117	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.00115	CbGpPWpGaD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	0.000182	0.00115	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—EGFR—chronic obstructive pulmonary disease	0.000181	0.00114	CbGpPWpGaD
Mitoxantrone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000553	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	0.00018	0.00113	CbGpPWpGaD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	0.00018	0.00113	CbGpPWpGaD
Mitoxantrone—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00018	0.00113	CbGpPWpGaD
Mitoxantrone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000549	CcSEcCtD
Mitoxantrone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.000549	CcSEcCtD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000177	0.00111	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000175	0.0011	CbGpPWpGaD
Mitoxantrone—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000533	CcSEcCtD
Mitoxantrone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000531	CcSEcCtD
Mitoxantrone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000531	CcSEcCtD
Mitoxantrone—ABCC1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000172	0.00108	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	0.000168	0.00105	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000166	0.00104	CbGpPWpGaD
Mitoxantrone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000162	0.00102	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000494	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.00016	0.001	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—IL6—chronic obstructive pulmonary disease	0.00016	0.001	CbGpPWpGaD
Mitoxantrone—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000482	CcSEcCtD
Mitoxantrone—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000155	0.000973	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000153	0.000963	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000153	0.00096	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000151	0.00095	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	0.00015	0.000944	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—IL6—chronic obstructive pulmonary disease	0.00015	0.000944	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000459	CcSEcCtD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000149	0.000935	CbGpPWpGaD
Mitoxantrone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000145	0.000913	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TLR2—chronic obstructive pulmonary disease	0.000144	0.000908	CbGpPWpGaD
Mitoxantrone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000143	0.000901	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000142	0.000894	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000141	0.000885	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00014	0.000882	CbGpPWpGaD
Mitoxantrone—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000427	CcSEcCtD
Mitoxantrone—Rash—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000423	CcSEcCtD
Mitoxantrone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000423	CcSEcCtD
Mitoxantrone—Headache—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00042	CcSEcCtD
Mitoxantrone—BTK—Immune System—KL—chronic obstructive pulmonary disease	0.000136	0.000853	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000135	0.000848	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000133	0.000836	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000133	0.000835	CbGpPWpGaD
Mitoxantrone—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000399	CcSEcCtD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000122	0.00077	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000122	0.000767	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.00012	0.000752	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000118	0.000744	CbGpPWpGaD
Mitoxantrone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000118	0.00074	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000114	0.000716	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000114	0.000715	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.000709	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GC—chronic obstructive pulmonary disease	0.000111	0.000696	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00011	0.000692	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD8A—chronic obstructive pulmonary disease	0.000109	0.000688	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.000109	0.000686	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000109	0.000686	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000109	0.000682	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GC—chronic obstructive pulmonary disease	0.000107	0.000673	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.000105	0.000658	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000104	0.000651	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000103	0.000647	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000102	0.000644	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000102	0.000643	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000102	0.00064	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.0001	0.000631	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.0001	0.000629	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.95e-05	0.000626	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	9.74e-05	0.000612	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	9.64e-05	0.000606	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CRP—chronic obstructive pulmonary disease	9.31e-05	0.000585	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.05e-05	0.000569	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TLR4—chronic obstructive pulmonary disease	8.92e-05	0.000561	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	8.87e-05	0.000557	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.83e-05	0.000555	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	8.82e-05	0.000555	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.61e-05	0.000541	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.49e-05	0.000534	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.2e-05	0.000515	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	8.17e-05	0.000514	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	8.14e-05	0.000511	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.93e-05	0.000498	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.77e-05	0.000488	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	7.6e-05	0.000478	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—EGFR—chronic obstructive pulmonary disease	7.59e-05	0.000477	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	7.29e-05	0.000458	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.19e-05	0.000452	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.18e-05	0.000451	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.08e-05	0.000445	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	6.99e-05	0.000439	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.6e-05	0.000415	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.51e-05	0.000409	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.5e-05	0.000409	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.26e-05	0.000393	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.17e-05	0.000388	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	6.07e-05	0.000381	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.05e-05	0.00038	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.98e-05	0.000376	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.85e-05	0.000368	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—IL6—chronic obstructive pulmonary disease	5.84e-05	0.000367	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL1B—chronic obstructive pulmonary disease	5.81e-05	0.000365	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.78e-05	0.000363	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KL—chronic obstructive pulmonary disease	5.64e-05	0.000355	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.57e-05	0.00035	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.45e-05	0.000343	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.41e-05	0.00034	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.39e-05	0.000339	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.32e-05	0.000334	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.3e-05	0.000333	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.28e-05	0.000332	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	5.27e-05	0.000331	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.26e-05	0.000331	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	5.03e-05	0.000316	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.03e-05	0.000316	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.9e-05	0.000308	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.86e-05	0.000305	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.8e-05	0.000302	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.66e-05	0.000293	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—EGFR—chronic obstructive pulmonary disease	4.42e-05	0.000278	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.42e-05	0.000278	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.38e-05	0.000275	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—chronic obstructive pulmonary disease	4.35e-05	0.000273	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	4.23e-05	0.000266	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.2e-05	0.000264	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.19e-05	0.000263	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.13e-05	0.00026	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.05e-05	0.000255	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.02e-05	0.000252	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4e-05	0.000251	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.94e-05	0.000247	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.85e-05	0.000242	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.82e-05	0.00024	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.78e-05	0.000237	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.75e-05	0.000236	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.73e-05	0.000234	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.69e-05	0.000232	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.65e-05	0.000229	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.64e-05	0.000229	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.53e-05	0.000222	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	3.53e-05	0.000222	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.45e-05	0.000217	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6—chronic obstructive pulmonary disease	3.4e-05	0.000214	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.39e-05	0.000213	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.33e-05	0.00021	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.31e-05	0.000208	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.24e-05	0.000204	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.21e-05	0.000202	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.17e-05	0.0002	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.02e-05	0.00019	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	2.97e-05	0.000187	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.88e-05	0.000181	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.84e-05	0.000179	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	2.83e-05	0.000178	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.65e-05	0.000166	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.61e-05	0.000164	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.59e-05	0.000163	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.52e-05	0.000158	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	2.48e-05	0.000156	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.43e-05	0.000153	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ALB—chronic obstructive pulmonary disease	2.4e-05	0.000151	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.39e-05	0.00015	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.37e-05	0.000149	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.31e-05	0.000145	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.3e-05	0.000144	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	2.18e-05	0.000137	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.09e-05	0.000131	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.99e-05	0.000125	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.97e-05	0.000124	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	1.87e-05	0.000118	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	1.84e-05	0.000116	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.83e-05	0.000115	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.77e-05	0.000111	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.75e-05	0.00011	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.74e-05	0.000109	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.6e-05	0.0001	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.57e-05	9.85e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.5e-05	9.43e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.47e-05	9.26e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	1.41e-05	8.88e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.23e-05	7.72e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.21e-05	7.61e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.18e-05	7.42e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.13e-05	7.1e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.13e-05	7.1e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.07e-05	6.73e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	7.27e-06	4.57e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.96e-06	4.37e-05	CbGpPWpGaD
